We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEXEA
176
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$149K 0.1%
+3,365
New +$162K
NAVI icon
177
Navient
NAVI
$793M
$144K 0.1%
10,821
+96
+0.9% +$1.21K
ELS icon
178
Equity Lifestyle Properties
ELS
$12.8B
$140K 0.1%
3,146
+2,772
+741% +$123K
AON icon
179
Aon
AON
$76B
$129K 0.09%
+964
New +$137K
GILD icon
180
PUT
Gilead Sciences
GILD
$162B
$126K 0.09%
20,000
– –
BWXT icon
181
BWX Technologies
BWXT
$16.2B
$121K 0.08%
+2,001
New +$121K
DCH
182
Dauch Corp
DCH
$1.33B
$119K 0.08%
6,971
-2,519
-27% -$44.6K
RCL icon
183
Royal Caribbean
RCL
$76B
$119K 0.08%
997
-2,318
-70% -$287K
BG icon
184
Bunge Global
BG
$23.7B
$118K 0.08%
1,761
+1,495
+562% +$102K
AIG icon
185
American International
AIG
$41.4B
$115K 0.08%
1,930
-98
-5% -$6.02K
UFS
186
DELISTED
DOMTAR CORPORATION (New)
UFS
$112K 0.08%
2,253
+6
+0.3% +$279
HAL icon
187
Halliburton
HAL
$27.3B
$104K 0.07%
2,137
-2,658
-55% -$117K
XLI icon
188
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$101K 0.07%
+1,338
New +$97.4K
GHC icon
189
Graham Holdings Company
GHC
$4.92B
$99K 0.07%
+178
New +$101K
VTLE
190
DELISTED
Vital Energy
VTLE
$99K 0.07%
466
-703
-60% -$154K
BXP icon
191
Boston Properties
BXP
$10.8B
$93K 0.06%
715
– –
NBR icon
192
Nabors Industries
NBR
$1.25B
$92K 0.06%
+269
New +$85.7K
KSS icon
193
Kohl's
KSS
$2.06B
$90K 0.06%
1,663
-1,357
-45% -$62.5K
LNC icon
194
Lincoln National
LNC
$7.81B
$90K 0.06%
+1,168
New +$88.4K
STT icon
195
State Street
STT
$50.6B
$90K 0.06%
917
-2,131
-70% -$204K
QQQ icon
196
PUT
Invesco QQQ Trust
QQQ
$460B
$83K 0.06%
14,500
– –
XLF icon
197
PUT
State Street Financial Select Sector SPDR ETF
XLF
$55.1B
$80K 0.06%
113,300
– –
META icon
198
PUT
Meta Platforms (Facebook)
META
$1.54T
$78K 0.05%
5,500
– –
RDN icon
199
Radian Group
RDN
$5.07B
$78K 0.05%
3,771
-1,200
-24% -$24.7K
SPLK
200
DELISTED
Splunk Inc
SPLK
$78K 0.05%
943
-1,785
-65% -$131K
6 7
8
9 10

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.